Section I. Migraine Management 1. Non-specific analgesics, combination analgesics, and antiemetics 2. The 5-HT1B and 5-HT1D Agonists in Acute Migraine Therapy: Ergotamine, dihydroergotamine, and the triptans 3. 5-HT1F agonists 4. CGRP receptor antagonists (Gepants) 5. Preventive treatment of migraine: Non-specific oral agents 6. OnabotulinumtoxinA: Discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment 7. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention 8. Nutraceuticals in migraine 9. Interventional treatments 10. Biobehavioral treatments of migraine 11. Physical treatment of migraine 12. Neuromodulation in migraine Section II. Guidelines 13. Evidence-based symptomatic treatment of migraine 14. Evidence-based preventive treatment of migraine Section III. Special Cases/Situations 15. Treatment in the emergency department 16. Special considerations in migraine during pregnancy and lactation 17. Special considerations in management of migraine in the elderly 18. Management of medication overuse headache Section IV. Outcome Measures 19. Outcome Measures for Migraine: Measuring the impact of migraine and results of migraine treatment Section V. Diagnosis and Treatment of Other Migraine Subtypes 20. Menstrually associated migraine 21. Hemiplegic migraine 22. Migraine with brainstem aura 23. Retinal migraine 24. Vestibular migraine and persistent postural perceptual dizziness 25. Status migrainosus 26. Persistent aura, visual snow, and other visual symptoms 27. Migrainous infarction 28. Migraine in children and adolescents: Assessment and diagnosis 29. Management of migraine in children and adolescents Section VI. Comorbidities of Migraine 30. Psychiatric comorbidities of migraine 31. Relationship of migraine and other forms of chronic pain 32. Comorbidities of migraine: Sleep disorders 33. The evolving concept of multimorbidity and migraine Section VII. Future Directions 34. Healthcare disparities faced by patients with migraine and potential mitigation strategies 35. Emerging and future directions of migraine research and treatment
